{"rows":[{"id":5902,"title":"Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders","authors":"Kathryn Fletcher, Jack Freestone, Nadine Ezard, Elizabeth Knock, Krista J. Siefried","journal":"Current Addiction Reports","publication_date":"2026-09-02","publication_year":2026,"doi":"10.1007/s40429-026-00783-7","pubmed_id":null,"openalex_id":"https://openalex.org/W7204988578","source_url":"https://doi.org/10.1007/s40429-026-00783-7","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Mechanism of Action,Emotional Processing,Mystical Experience,Randomized Controlled Trial,Review Article,Observational Study,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-09 01:20:58","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00783-7","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00783-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00783-7","source_url":"https://doi.org/10.1007/s40429-026-00783-7","doi":"10.1007/s40429-026-00783-7","pmid":"","publication_date":"2026-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5869,"title":"The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies","authors":"Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis","journal":"Current Addiction Reports","publication_date":"2026-08-18","publication_year":2026,"doi":"10.1007/s40429-026-00774-8","pubmed_id":null,"openalex_id":"https://openalex.org/W7203711549","source_url":"https://doi.org/10.1007/s40429-026-00774-8","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-20 01:20:19","last_checked":"2026-08-25 01:21:02","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00774-8","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00774-8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00774-8","source_url":"https://doi.org/10.1007/s40429-026-00774-8","doi":"10.1007/s40429-026-00774-8","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5074,"title":"Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis","authors":"Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić","journal":"Current Addiction Reports","publication_date":"2021-07-26","publication_year":2021,"doi":"10.1007/s40429-021-00385-5","pubmed_id":null,"openalex_id":"https://openalex.org/W3186726344","source_url":"https://doi.org/10.1007/s40429-021-00385-5","substance_tags":"psilocybin","topic_tags":"End-of-Life Distress,Receptor Pharmacology,Review Article,Safety,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:45","bibtex":null,"source_record_id":"DOI:10.1007/s40429-021-00385-5","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-021-00385-5","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-021-00385-5","source_url":"https://doi.org/10.1007/s40429-021-00385-5","doi":"10.1007/s40429-021-00385-5","pmid":"","publication_date":"2021-07-26","importer_version":"2.1.3","text_redistributed":false}},{"id":3937,"title":"New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues","authors":"Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento","journal":"Current Addiction Reports","publication_date":"2019-04-22","publication_year":2019,"doi":"10.1007/s40429-019-00249-z","pubmed_id":null,"openalex_id":"https://openalex.org/W2940982719","source_url":"https://doi.org/10.1007/s40429-019-00249-z","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Consciousness,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-07-02 20:42:13","bibtex":null,"source_record_id":"DOI:10.1007/s40429-019-00249-z","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-019-00249-z","source_url":"https://doi.org/10.1007/s40429-019-00249-z","doi":"10.1007/s40429-019-00249-z","pmid":"","publication_date":"2019-04-22","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Current Addiction Reports","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}